Disease Education Resources
Oncology
Explore our library of Lilly-created medical education resources. Please note: These resources do not offer CME/CE credit.
Breast Cancer - Metastatic
ER Antagonists and Molecular Attributes
This video reviews oral ER antagonists targeting wildtype and ESR1-mutated ER in ER+/HER2- MBC, including how they differ from traditional endocrine therapies and currently FDA-approved agents, their indications, and mechanisms of action.
ER+, HER2- Metastatic Breast Cancer: Hypothetical Patient Case
An interactive hypothetical patient case study for healthcare providers focused on patients with ET-resistant ER+, HER2- MBC
HR+, HER2- Metastatic Breast Cancer
Educational site offering an overview of HR+, HER2- metastatic breast cancer and the current treatment landscape.
MBC Patient Case Outline
Hypothetical patient case demonstrating how clinicians navigate the complex process of determining the next line of therapy when a patient with metastatic breast cancer experiences progression while receiving CDK4/6 inhibitor therapy.
The ER pathway in MBC and its Role in Disease Progression
An overview on on how the ER pathway drives tumor growth, what drives resistance to endocrine therapy, and the current unmet needs in ER-positive, HER2-negative mBC.
Tx Journey and Unmet Need for Pts who Progress on ET
An overview on what happens after 1L progression when resistance, specifically ESR1 mutations, emerges, and practical resistance monitoring strategies.
Hypothetical patient case deck regarding resistance to Endocrine Therapy in ER+, HER2- Metastatic Breast Cancer.
Hypothetical patient case infographic regarding resistance to Endocrine Therapy in ER+, HER2- Metastatic Breast Cancer.
Patient Education Resources
Explore our library of patient based education materials to aid in HCP to patient interactions.